FMR CORP 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
FMR CORP | 0 0.000% |
-4,575,536 (Position Closed) |
Filing |
| 2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
FMR CORP | 4,575,536 11.060% |
4,251,667 (+1312.77%) |
Filing |